Another cholesterol drug seeks OTC status

Now Pravachol is up to the plate. It too will be unlikely to be approved for OTC status. The pharmaceuticals are desperate to salvage profits in light of their expiring statin patents.

Related posts:

1. Doesn’t the FDA have better things to do than to target Cheerios?
2. Zero tolerance for adverse drug events
3. Statin box office
4. Should you stop taking Vytorin if you’re already on the drug?
5. Prescription drug abuse
6. Pfizer gives up on cardiac drugs
7. Brewer: Falling HDLs due to generic statins?

  Follow on Twitter   Subscribe